Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement-Reference-Cited by-同舟云学术

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Published:2018-07-09 Issue:3 Volume:54 Page:353-367
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gonsalves Wilson I.,Buadi Francis K.,Ailawadhi Sikander,Bergsagel P. Leif^ORCID,Chanan Khan Asher A.,Dingli David,Dispenzieri Angela,Fonseca Rafael,Hayman Susan R.,Kapoor Prashant,Kourelis Taxiarchis V.,Lacy Martha Q.,Larsen Jeremy T.,Muchtar Eli^ORCID,Reeder Craig B.,Sher Taimur,Stewart A. Keith,Warsame Rahma,Go Ronald S.,Kyle Robert A.,Leung Nelson^ORCID,Lin Yi,Lust John A.,Russell Stephen J.,Zeldenrust Stephen R.,Fonder Amie L.,Hwa Yi L.,Hobbs Miriam A.,Mayo Angela A.,Hogan William J.^ORCID,Rajkumar S. Vincent,Kumar Shaji K.,Gertz Morie A.,Roy Vivek

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0264-8.pdf

Reference138 articles.

1. Auner HW, Szydlo R, Hoek J, Goldschmidt H, Stoppa AM, Morgan GJ, et al. Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Bone Marrow Transplant. 2015;50:209–15.

2. Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, et al. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant. 2013;19:1615–24.

3. Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc. 2013;88:360–76.